Anyone using the same product (cells) can progress straight to phase 2. If safety is proven for a given delivery method, anyone utilising that same product and delivery method can bypass the phase 1 safety trials as they have no been done. Same as saying if a drug is approved for use in one condition and you want to see if it works for another you don't have to start from scratch with phase 1 trials again. You get to go straight to efficacy trials. Unsure if this will translate to inhalation delivery for asthma?
Anyone using the same product (cells) can progress straight to...
-
- There are more pages in this discussion • 51 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $52.99M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 29.5¢ | 27.5¢ | $29.94K | 106.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | 27.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.5¢ | 10159 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| CYP (ASX) Chart |